21
Participants
Start Date
March 21, 2017
Primary Completion Date
January 13, 2020
Study Completion Date
February 10, 2020
High-Dose Conformal Radiation Therapy
"24 Gy in 3 fractions of 8Gy each for bone and/or soft tissue lesions~30 Gy in 5 fractions of 6 Gy each for prostate gland"
Pembrolizumab
200 mg
University of Virginia, Charlottesville
James Larner, MD
OTHER